Multiple Sclerosis (not finished)

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/110

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 7:47 PM on 9/13/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

111 Terms

1
New cards

What is multiple sclerosis (MS)?

A chronic, progressive autoimmune disease in which the immune system attacks the myelin sheath surrounding nerve fibers in the brain and spinal cord which leads to impaired motor and autonomic function

2
New cards
How does demyelination in MS affect nerve function?
Nerves can no longer properly conduct electrical impulses → impaired motor and autonomic function
3
New cards
What are common early symptoms of MS?
Fatigue, weakness, tingling, numbness, and blurred vision
4
New cards

What symptoms can occur as MS progresses?

Cognitive decline, muscle spasms, pain, bladder spasticity, depression, heat sensitivity, sexual dysfunction, gait instability, and visual disturbances

5
New cards

What will 30% of patients with MS develop if left untreated?

significant physical disability

6
New cards
Which type of MS generally has the worst prognosis?
Primary progressive MS
7
New cards

How are primary, secondary, and tertiary MS symptoms characterized?

Primary = muscle weakness;

secondary = consequences of primary symptoms

tertiary = psychological and social concerns

8
New cards
What sex and age groups are most commonly affected by MS?
Females more than males (2:1), typically ages 20–40
9
New cards
How does MS tend to differ between males and females?
MS is more common in females, but males are more likely to have progressive disease
10
New cards
What tests are used to help diagnose MS?
Symptoms plus MRI of brain/spinal lesions, spinal fluid analysis, and evoked potentials
11
New cards
What is a primary goal of MS therapy?
Prevent disease progression because lost neuronal function cannot be regained
12
New cards
What non-drug approaches are used in MS management?
Functional rehabilitation, anti-inflammatory diet, emotional support, vocational/cognitive rehabilitation, and physical/occupational therapy
13
New cards
How are acute MS relapses typically treated?
3–7 days of IV methylprednisolone with or without an oral steroid taper
14
New cards
What is the purpose of disease-modifying therapies (DMTs) in MS?
Reduce the frequency and severity of relapses
15
New cards
Which parenteral DMTs were historically the mainstay for relapsing MS and remain preferred when considering pregnancy?
Interferon beta formulations and glatiramer acetate
16
New cards

Pegylated interferon beta allows for SC dosing every ____

14 days

17
New cards

Which oral DMTs are often used as initial treatment for relapsing-remitting MS?

Fingolimod, diroximel fumarate, and ozanimod

18
New cards
What higher-risk MS therapies are generally second- or third-line but may be first-line for aggressive disease?
Monoclonal antibodies and chemotherapy drugs
19
New cards
What is the mechanism of action of glatiramer acetate?
Immune modulator thought to activate T-lymphocyte suppressor cells in relapsing MS
20
New cards

What is the brand name and dosing of glatiramer acetate

Copaxone; SC daily or 3 times per week at least 48 hours apart

21
New cards
How should the 3-times-weekly glatiramer acetate regimen be administered?
On the same 3 days each week with doses ≥48 hours apart
22
New cards
Are the 20 mg/mL and 40 mg/mL glatiramer acetate concentrations interchangeable?
No
23
New cards

What is the boxed warning for glatiramer acetate?

Anaphylaxis, which can occur at any time

24
New cards
What major warnings are associated with glatiramer acetate?
Chest pain, immediate post-injection reaction, and lipoatrophy
25
New cards
What are common adverse effects of glatiramer acetate?
Injection-site reactions, flushing, diaphoresis, dyspnea, infection, pain, weakness, rash, anxiety, nausea, nasopharyngitis, and vasodilation
26
New cards

What is the preferred medication for MS in a pregnant person?

glatiramer acetate

27
New cards
What should be checked before administering glatiramer acetate?
Check the solution for discoloration and discard if present
28
New cards
How should glatiramer acetate be stored?
Refrigeration preferred; may be kept at room temperature for up to 1 month
29
New cards
What should be done before injecting refrigerated glatiramer acetate?
Allow it to stand at room temperature for 20 minutes
30
New cards
What is the general mechanism of action of interferon beta products in MS?
Alter expression and response to surface antigens → enhance immune cell function
31
New cards
What are the routes of administration for interferon beta products?
SC except Avonex, which is IM
32
New cards
What is the dosing of interferon beta-1a (Avonex)?
IM once weekly
33
New cards
What is the dosing of interferon beta-1a (Rebif)?
SC 3 times per week at least 48 hours apart
34
New cards
What is the dosing of interferon beta-1b (Betaseron, Extavia)?
SC every other day
35
New cards
What is the dosing of peginterferon beta-1a (Plegridy)?
SC every 14 days
36
New cards
What major warnings are associated with interferon beta products?
Psychiatric disorders including depression/suicide, injection-site necrosis, myelosuppression, increased LFTs, thyroid dysfunction, infections, anaphylaxis, worsening cardiovascular disease, and seizures
37
New cards
What is a characteristic adverse effect of interferon beta products?
Flu-like symptoms following administration that can last minutes to hours
38
New cards
How can flu-like symptoms from interferon beta products be managed?
Acetaminophen or NSAIDs before injection and/or start at a lower dose and titrate weekly
39
New cards
What are other common adverse effects of interferon beta products?
Visual disturbances, fatigue, depression, pain, UTI, and headache
40
New cards
What should be monitored with interferon beta products?
LFTs, CBC, and thyroid function
41
New cards
How should LFTs and CBC be monitored with interferon beta products?
At 1, 3, and 6 months, then periodically
42
New cards
How should thyroid function be monitored with interferon beta products?
Every 6 months if thyroid dysfunction is present or as clinically necessary
43
New cards
Which interferon beta products can be stored at room temperature?
Betaseron and Extavia
44
New cards
What administration precaution applies to prefilled interferon beta syringes?
Do not expel the air bubble because this can cause loss of dose
45
New cards
Which interferon beta products should NOT be shaken?
Avonex, Betaseron, and Extavia
46
New cards
Why may some interferon beta formulations be inappropriate for patients with albumin sensitivity?
Some contain albumin
47
New cards
What is the mechanism of action of S1P receptor modulators in MS?
Block lymphocytes from exiting lymph nodes → reduce peripheral lymphocytes and may limit lymphocyte migration into the CNS
48
New cards
Which drugs are S1P receptor modulators?
Fingolimod, ozanimod, ponesimod, and siponimod
49
New cards
What cardiovascular conditions contraindicate S1P receptor modulators?
Specific heart blocks or MI, unstable angina, stroke, TIA, or decompensated heart failure within the past 6 months
50
New cards
What additional contraindications apply to ozanimod and siponimod?
Ozanimod: severe untreated sleep apnea or concomitant MAOI use; siponimod: CYP2C9*3/*3 genotype
51
New cards
What important cardiac adverse effects occur with S1P receptor modulators?
Bradycardia and other bradyarrhythmias
52
New cards
What first-dose monitoring is required with fingolimod?
Monitor for at least 6 hours with ECG at baseline and at the end of observation
53
New cards
What infection precautions apply to S1P receptor modulators?
Increased infection risk; monitor CBC, screen for VZV antibodies, and vaccinate if nonimmune
54
New cards
What other major adverse effects occur with S1P receptor modulators?
Increased LFTs, hypertension, decreased lung function, macular edema, and fetal risk
55
New cards
What monitoring is required for macular edema with S1P receptor modulators?
Eye exams
56
New cards
What pregnancy counseling applies to S1P receptor modulators?
Use contraception during treatment and for 7–90 days after stopping depending on the drug
57
New cards
What important counseling applies when stopping an S1P receptor modulator?
MS can become much worse after discontinuation
58
New cards
What is the mechanism of action of fumarates used for MS?
Nrf2 activators with anti-inflammatory and cytoprotective effects
59
New cards
Which fumarates are used for MS?
Dimethyl fumarate, diroximel fumarate, and monomethyl fumarate
60
New cards
What major warnings are associated with fumarates?
Hepatotoxicity, reversible neutropenia, and PML
61
New cards
What common adverse effects occur with fumarates?
Flushing and GI effects such as N/V/D, abdominal pain, and dyspepsia
62
New cards
How can flushing from fumarates be reduced?
Aspirin 30 minutes before the dose and administration with food
63
New cards
Which fumarate causes fewer GI adverse effects?
Diroximel fumarate (Vumerity)
64
New cards
How should fumarate capsules be administered?
Do not crush, chew, or sprinkle capsule contents on food
65
New cards
What is the relationship among dimethyl fumarate, diroximel fumarate, and monomethyl fumarate?
Monomethyl fumarate is the active metabolite of dimethyl fumarate and diroximel fumarate
66
New cards
What is the mechanism of action of teriflunomide?
Inhibits pyrimidine synthesis → anti-inflammatory effects and may reduce activated lymphocytes in the CNS
67
New cards
What are the major contraindications to teriflunomide?
Pregnancy due to teratogenicity and severe hepatic impairment due to hepatotoxicity
68
New cards
What is the relationship between teriflunomide and leflunomide?
Teriflunomide is the active metabolite of leflunomide
69
New cards
How can teriflunomide be rapidly removed from the body?
Accelerated elimination procedure
70
New cards
Which CD20-directed monoclonal antibodies are used for MS?
Ofatumumab, ublituximab, and ocrelizumab
71
New cards
What must be screened for before starting a CD20-directed monoclonal antibody?
Active hepatitis B infection
72
New cards
What major warnings are associated with CD20-directed monoclonal antibodies?
Serious infections including PML, fetal risk, infusion reactions, and decreased immunoglobulin levels
73
New cards
What vaccine precaution applies to CD20-directed monoclonal antibodies?
Avoid live vaccines during treatment
74
New cards
Which CD20-directed monoclonal antibody can cause immune-mediated colitis?
Ocrelizumab
75
New cards
Which CD20-directed monoclonal antibodies are indicated for relapsing forms of MS?
Ublituximab and ocrelizumab
76
New cards
How should patients be premedicated for ublituximab or ocrelizumab?
Steroid plus an antihistamine and/or acetaminophen
77
New cards
What special administration requirement applies to ocrelizumab?
Requires a 0.22-micron in-line filter
78
New cards
What is the mechanism of action of alemtuzumab?
CD52-directed cytolytic monoclonal antibody
79
New cards
What are the boxed warnings for alemtuzumab?
Serious/fatal autoimmune conditions, infusion reactions, malignancies, and stroke
80
New cards
What is a contraindication to alemtuzumab?
HIV because it causes prolonged decreases in CD4 count
81
New cards
When is alemtuzumab generally used for MS?
After an inadequate response to ≥2 MS drugs
82
New cards
What vaccine counseling applies before alemtuzumab?
Complete all vaccinations at least 6 weeks before treatment
83
New cards
How should patients be premedicated before alemtuzumab?
Steroid plus an antihistamine and/or acetaminophen
84
New cards
What is the mechanism of action of natalizumab?
Monoclonal antibody that binds the alpha-4 subunit of integrin molecules
85
New cards
What is the boxed warning for natalizumab?
Progressive multifocal leukoencephalopathy (PML)
86
New cards
What special prescribing program is required for natalizumab?
TOUCH Prescribing Program REMS
87
New cards
What major warnings are associated with natalizumab?
Herpes encephalitis/meningitis, hepatotoxicity, hypersensitivity, and immunosuppression/infections
88
New cards
What are common adverse effects of natalizumab?
Infusion reactions, headache, fatigue, arthralgia, nausea, rash, depression, gastroenteritis, and abdominal/back pain
89
New cards
How often is natalizumab administered?
Every 4 weeks
90
New cards
What medications should not be used with natalizumab?
Other immunosuppressants
91
New cards
What administration precautions apply to natalizumab?
Stable in normal saline only and do not shake
92
New cards
What are the boxed warnings for cladribine (Mavenclad)?
Malignancies and teratogenicity
93
New cards
What are the contraindications to cladribine?
Current malignancy, HIV, or active chronic infections
94
New cards
What contraception counseling applies to cladribine?
Males and females of reproductive potential should use contraception during treatment and for 6 months after the last dose
95
New cards
What is the mechanism of action of dalfampridine (Ampyra)?
Potassium channel blocker that may increase nerve signal conduction
96
New cards
What is the role of dalfampridine in MS?
Symptom treatment that increases walking speed; it is not disease-modifying
97
New cards
What major contraindication applies to dalfampridine?
History of seizures
98
New cards
How long may dalfampridine take to show efficacy?
Up to 6 weeks, and most patients do not respond
99
New cards
Which medications can be used for MS-related incontinence?
Anticholinergics
100
New cards
Which medications can be used for constipation and diarrhea in MS?
Laxatives for constipation and loperamide for diarrhea